Insider · CIK 0001739816

Boyd Peter E.

Reports to the SEC for 1 company · WARREN, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001739816

Forms 4 and 5

Insider transactions

33 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-09	AQSTAquestive Therapeutics, Inc. · Warrant (Right to Buy)X Exercise of In-Money	Chief People Officer	XExercise of In-Money	−2,293 sh	—	—	0
2026-09-09	AQSTAquestive Therapeutics, Inc.X Exercise of In-Money	Chief People Officer	XExercise of In-Money	+2,293 sh	$0.96	+$2,201.28	284,024
2026-05-05	AQSTAquestive Therapeutics, Inc.F Tax Payment	Chief People Officer	FTax Payment	−56.8K sh	$4.18	−$237K	281,731
2026-03-10	AQSTAquestive Therapeutics, Inc.S Sale	Chief People Officer	SSale	−29.8K sh	$4.17	−$124K	338,509
2026-03-09	AQSTAquestive Therapeutics, Inc.A Award	Chief People Officer	AAward	+80K sh	—	—	368,323
2026-03-09	AQSTAquestive Therapeutics, Inc. · Non-Qualified Stock Option (right to buy)A Award	Chief People Officer	AAward	+42.5K sh	$4.29	+$182K	42,500
2025-12-04	AQSTAquestive Therapeutics, Inc.A Award	Chief People Officer	AAward	+20K sh	—	—	288,323
2025-10-15	AQSTAquestive Therapeutics, Inc.S Sale	Chief People Officer	SSale	−10K sh	$7.00	−$70K	268,323
2025-09-26	AQSTAquestive Therapeutics, Inc.S Sale	Chief People Officer	SSale	−10K sh	$6.30	−$63K	278,323
2025-09-05	AQSTAquestive Therapeutics, Inc.S Sale	Chief People Officer	SSale	−15K sh	$5.30	−$79.5K	288,323
2025-03-09	AQSTAquestive Therapeutics, Inc.F Tax Payment	Chief People Officer	FTax Payment	−7,681 sh	$2.65	−$20.4K	303,323
2025-03-07	AQSTAquestive Therapeutics, Inc. · Performance Stock UnitsA Award	Chief People Officer	AAward	+60K sh	—	—	60,000
2025-03-07	AQSTAquestive Therapeutics, Inc. · Non-Qualified Stock Option (right to buy)A Award	Chief People Officer	AAward	+40K sh	—	—	40,000
2025-03-07	AQSTAquestive Therapeutics, Inc.A Award	Chief People Officer	AAward	+80K sh	—	—	317,628
2025-03-07	AQSTAquestive Therapeutics, Inc.F Tax Payment	Chief People Officer	FTax Payment	−6,624 sh	$2.65	−$17.6K	311,004
2024-03-09	AQSTAquestive Therapeutics, Inc.F Tax Payment	Chief People Officer	FTax Payment	−8,370 sh	$4.88	−$40.8K	237,628
2024-03-07	AQSTAquestive Therapeutics, Inc.A Award	Chief People Officer	AAward	+86.3K sh	—	—	245,998
2024-03-07	AQSTAquestive Therapeutics, Inc. · Non-Qualified Stock Option (right to buy)A Award	Chief People Officer	AAward	+43.1K sh	—	—	43,125
2023-08-09	AQSTAquestive Therapeutics, Inc. · Performance Stock UnitsA Award	Chief People Officer	AAward	+50K sh	—	—	50,000
2023-05-05	AQSTAquestive Therapeutics, Inc. · Performance Stock UnitsA Award	Chief People Officer	AAward	+50K sh	—	—	50,000
2023-03-09	AQSTAquestive Therapeutics, Inc.A Award	Chief People Officer	AAward	+100K sh	—	—	159,532
2022-11-04	AQSTAquestive Therapeutics, Inc. · Non-Qualified Stock Option (right to buy)A Award	Chief People Officer	AAward	+25K sh	—	—	25,000
2022-06-14	AQSTAquestive Therapeutics, Inc.P Purchase	Chief People Officer	PPurchase	+5,000 sh	$0.81	+$4,050	59,532
2022-06-08	AQSTAquestive Therapeutics, Inc. · Warrant (Right to Buy)P Purchase	Chief People Officer	PPurchase	+2,293 sh	$0.13	+$298.09	2,293
2022-06-08	AQSTAquestive Therapeutics, Inc.P Purchase	Chief People Officer	PPurchase	+2,293 sh	$0.96	+$2,201.28	54,532
2022-03-10	AQSTAquestive Therapeutics, Inc. · Non-Qualified Stock Option (right to buy)A Award	Chief People Officer	AAward	+70K sh	—	—	70,000
2021-03-11	AQSTAquestive Therapeutics, Inc. · Non-Qualified Stock Option (right to buy)A Award	Chief People Officer	AAward	+35K sh	—	—	35,000
2020-03-16	AQSTAquestive Therapeutics, Inc. · Non-Qualified Stock Option (right to buy)A Award	Chief People Officer	AAward	+50.7K sh	—	—	50,700
2020-03-16	AQSTAquestive Therapeutics, Inc.P Purchase	Chief People Officer	PPurchase	+2,000 sh	$1.50	+$3,000	52,239
2019-08-12	AQSTAquestive Therapeutics, Inc.P Purchase	Chief People Officer	PPurchase	+600 sh	$3.81	+$2,286	50,239
2019-02-28	AQSTAquestive Therapeutics, Inc. · Non-Qualified Stock Option (right to buy)A Award	Chief People Officer	AAward	+30K sh	—	—	30,000
2018-11-21	AQSTAquestive Therapeutics, Inc.P Purchase	Chief People Officer	PPurchase	+200 sh	$9.98	+$1,996	49,639
2018-07-24	AQSTAquestive Therapeutics, Inc. · Stock Option (Right to Purchase)A Award	Chief People Officer	AAward	+36.2K sh	—	—	36,223

Recent filings

Accepted (ET)
Sep 104
Boyd Peter E.0001214659-26-011541
SEC(opens sec.gov)
May 74
Boyd Peter E.0001214659-26-005751
SEC(opens sec.gov)
Apr 134
Boyd Peter E.0001214659-26-004596
SEC(opens sec.gov)
Mar 114
Boyd Peter E.0001214659-26-003147
SEC(opens sec.gov)
Dec 54
Boyd Peter E.0001214659-25-017652
SEC(opens sec.gov)
Oct 174
Boyd Peter E.0001214659-25-015046
SEC(opens sec.gov)
Sep 294
Boyd Peter E.0001214659-25-014287
SEC(opens sec.gov)
Sep 84
Boyd Peter E.0001214659-25-013485
SEC(opens sec.gov)
Mar 114
Boyd Peter E.0001214659-25-004222
SEC(opens sec.gov)
Mar 124
Boyd Peter E.0001214659-24-004394
SEC(opens sec.gov)
Mar 114
Boyd Peter E.0001214659-24-004303
SEC(opens sec.gov)
Aug 94
Boyd Peter E.0001214659-23-010925
SEC(opens sec.gov)
May 54
Boyd Peter E.0001214659-23-006555
SEC(opens sec.gov)

Companies

Aquestive Therapeutics, Inc.Chief People OfficerAQST

Address

C/O AQUESTIVE THERAPEUTICS, INC. 30 TECHNOLOGY DRIVE

WARREN, NJ, 07059